University of Leipzig
Leipzig, Germany
Completed
NCT Number: NCT03523481
NHF in Acute Hypercapnic Acute Exacerbation of COPD
Patients with AECOPD and NIV failure and in absence will be treated with NHF device. Inclusion criteria are pH < 7,38 and pCO2 > 45 mm Hg. Patients were treated if pH >7,38 or refusal of therapy.
Completed
Looking for future studies?
Notify MeKey information
Conditions
Sex eligibility
All sexes
Study type
Observational
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- pH < 7,38
- hypercapnic AECOPD
Exclusion criteria
- Need of intubation
Treatment and study plan
Primary outcomes
-
pH
Time frame: up to 24 hours
Increase in pH
Secondary outcomes
-
pCO2
Time frame: up to 24 hours
Decrease in pCO2
Sponsors and collaborators
Lead sponsor
Jens Bräunlich, MD
Other
Registry information
Important dates
- Study start
- 2018
- Primary completion
- 2018
- Study completion
- 2018
- First posted
- May 14, 2018
- Registry last updated
- Jun 25, 2018
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.